Asthma control is reached in a large majority of severe asthmatics treated with omalizumab. An Italian observational study

被引：0
|
作者：
Novelli, F. [1 ]
Lenzini, G. [1 ]
Latorre, M. [1 ]
Paggiaro, P. [1 ]
机构：
[1] Univ Pisa, Pisa, Italy
来源：
ALLERGY | 2013年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：375 / 375
页数：1
相关论文
共 50 条
  • [31] OMALIZUMAB IMPROVES QUALITY OF LIFE AND ASTHMA CONTROL IN CHINESE PATIENTS WITH MODERATE-TO-SEVERE ASTHMA: A RANDOMIZED PHASE III STUDY
    Li, J.
    Kang, J.
    Canvin, J.
    Wang, C.
    Zhong Nanshan
    Yang, J.
    Humphries, M.
    RESPIROLOGY, 2014, 19 : 2 - 2
  • [32] Decreased Exacerbations and Improvement in Asthma Symptom Control in Asthma COPD Overlap Treated With Omalizumab: Data From the Prospero Cohort Study
    Hanania, Nicola
    Chipps, Bradley
    Griffin, Noelle
    Trzaskoma, Benjamin
    Iqbal, Ahmar
    Casale, Thomas
    CHEST, 2017, 152 (04) : 776A - 776A
  • [33] Results of the cross sectional phase of the PROXIMA study, an Italian observational two phase study of severe allergic asthma patients to determine the prevalence of perennial vs seasonal asthma and to evaluate asthma control
    Bargagli, E.
    Bucca, C.
    Zappa, M. C.
    Berlendis, M.
    Michetti, G.
    Rigoni, L.
    Canonica, W. G.
    ALLERGY, 2016, 71 : 537 - 537
  • [34] Omalizumab for Chinese patients with moderate-to-severe allergic asthma in real-world clinical setting: a prospective, observational study
    Wang, Wen
    Li, Jieying
    Zou, Congying
    Zhao, Lifang
    Zhu, Ya
    Guo, Yue
    Wang, Feiran
    BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [35] Serum GAL3 predict response in omalizumab-treated patients with severe allergic asthma: the PROXIMA study
    Riccio, Anna Maria
    Mauri, Pierluigi
    Bartezaghi, Marta
    Saccheri, Fabiana
    Canonica, Giorgio Walter
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [36] Asthma Control As Patient Reported Outcome (PRO) In Asthmatics Treated With ICS/LABA Combinations In The Cross-Sectional Phase Of The Prospective Study On Asthma Control (PRISMA)
    Allegra, L.
    Cremonesi, G.
    Girbino, G.
    Ingrassia, E.
    Marsico, S.
    Nicolini, G.
    Terzano, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [37] Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment
    Campo, Paloma
    Soto Campos, Gregorio
    Moreira, Ana
    Quirce, Santiago
    Padilla-Galo, Alicia
    Martinez-Moragon, Eva
    Mardones, Aizea
    Davila, Ignacio
    ALLERGY, 2021, 76 (06) : 1868 - 1872
  • [38] Interim analysis of a prospective study investigating oral corticosteroid (OCS) use in omalizumab treated severe allergic asthma patients: APEX II study
    Niven, Rob
    Bucknall, Christine
    Chaudhuri, Rekha
    Kurukulaaratchy, Ramesh
    De Lorio, Fosca
    Menzies-Gow, Andrew
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [39] BLOOD PRESSURE CONTROL IN TREATED HYPERTENSIVES:RESULTS FROM DIGIT (STUDIO ITALIANO SULLA GESTIONE DELL'IPERTENSIONE) A LARGE OBSERVATIONAL STUDY ON ITALIAN TREATED HYPERTENSIVES
    Mancia, G.
    Bianco, S.
    Giannattasio, C.
    JOURNAL OF HYPERTENSION, 2010, 28 : E208 - E208
  • [40] Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA - an observational, 2 phase, patient reported outcomes study
    Canonica G.W.
    Bartezaghi M.
    Marino R.
    Rigoni L.
    Clinical and Molecular Allergy, 13 (1)
12345